Abstract
Several experimental brain edema models are currently available for drug evaluation. Brain edemas are essentially vasogenic and/or cytotoxic, and eicosanoids are involved in the development of these edemas. Thus, a new model developed in our laboratory, which was obtained by phospholipase A2 intracerebral injection was used to study the antiinflammatory effect of clonidine. The copper wire edema model was chosen as reference.
Edemas wer evaluated by determining the swelling and Na+ and K+ tissue concentrations of each hemisphere. Drugs were administered intraperitoneally.
Dexamethasone was the only drug to inhibit copper wire-induced edema, whereas indomethacin and clonidine as well as dexamethasone exhibited marked antiedematous activity in our model. The effect of clonidine, which could be inhibited by prior administration of yohimbine, suggests that central α2 stimulation is involved in reducing experimental brain edema.
Similar content being viewed by others
References
A. Verier, M. Jomin, G. Lozes and F. Lesoin,L'oedème cérébral post-traumatique: Physiopathologie et thérapeutique. Sem. Hôp. Paris60, 673–677 (1984).
Y. Inaba, I. Klatzo and M. Spatz, Brain Edema, Springer Verlag, Berlin (1985).
F. Iannotti, H. A. Crockard, G. Ladds and L. Symon,Are prostaglandins involved in experimental ischaemic edema in gerbils?. Stroke12, 301–306 (1981).
P. T. Lascelles, K. K. Bhakoo and H. A. Crockard,The role of prostaglandins in ischaemic cerebral edema. Clinical Sci.61 (3), 64 (1981).
K. Bhakoo, H. A. Crockard, P. C. Lascelles, F. R. C. Path and S. F. Avery,Prostaglandin synthesis and edema formation during reperfusion following experimental brain ischaemia in the gerbil. Stroke15, 891–895 (1984).
N. G. Bazan and E. B. Rodriguez de Turco,Membrane lipids in the pathogenesis of brain edema: Phospholipids and arachidonic acid, the earliest membrane components changed at the onset of ischaemia. in: Brain edema, Adv. in Neurology28, 197–205 (1980).
E. P. Wei, E. F. Ellis and H. A. Kontos,Role of prostaglandins in pial arteriolar response to CO 2 and hypoxia. Am. J. Physiol.238, H226-H230 (1980).
T. Koide, O. Gotoh, T. Asano and K. Takakura,Alterations of eicosanoid synthetic capacity of rat brain microvessels following ischaemia: Relevance to ischaemic brain edema. J. Neurochem.44, 85–93 (1985).
S. Levine, N. Casner, R. Compitello, A. M. Saad and F. M. Plakogiannis,Reduction of inflammatory brain edema by non-steroidal anti-inflammatory drugs. Exp. Neurol74, 370–378 (1981).
M. P. Holsapple, A. Malave, M. T. Lowy and G. K. W. Yin,Central and peripheral anti-inflammatory actions by clonidine and a structurally related imidazoline analog. J. Pharmacol. Exp. Ther.229, 399–403 (1984).
S. K. Kulkarni, A. K. Mehta and J. Kunchandy,Antiinflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw edema in rats. Arch. Int. Pharmacodyn.279, 324–334 (1986).
M. Jugé, J. Y. Petit, R. Y. Sanchez, A. Pineau and L. Welin,Effects d'un anti-inflammatoire à structure benzamide, de la dexaméthasone et de l'indométacine sur l'oedème cérébral expérimental à la phospholipase A 2 chez le Rat. C. R. Acad. Sci. Paris307, 529–534 (1988).
K. A. C. Elliot and H. Jasper,Measurement of experimentally induced brain swelling and shrinkage. Am. J. Physiol.157, 122–129 (1949).
S. Robert-Piessard, G. Le Baut, J. Courant, J. D. Brion, L. Sparfel, S. Bouhayat, J. Y. Petit, R. Y. Sanchez, M. Jugé, N. Grimaud and L. Welin,Non-acidic anti-inflammatory compounds: Activity of N-(4,6-dimethyl-2-pyridinyl) benzamides and derivatives. Eur. J. Med. Chem.25, 9–19 (1990).
F. Piriou, J. Y. Petit and L. Welin,Benzamide potentiation of behavioural apomorphine induced effects; mechanism involved. Experientia41, 1409–1410 (1985).
C. A. Chan, R. A. Fishman, J. Caronna, W. Schmidley, G. Prioleau and J. Lee,Induction of brain edema following intracerebral injection of arachidonic acid. Ann. Neurol.13, 625–632 (1983).
S. Garattini, A. Jori, C. Bernardi, C. Carrara, S. Paglialunga and D. Segre,Sensitivity of local edemas to systemic pharmacological effects. Proc. International Symposium on Nonsteroidal Anti-inflammatory Drugs, pp. 151–161, Excerpta Medica Foundation, London (1965).
M. Laubie and H. Schmitt,Effets hémodynamiques du ST 155, 2-(2,6 dichlorophenylamino)-2 imidazoline hydrochloride, chez le chien hypertendu. Arch. Inter. Pharmacodyn.179, 23–35 (1969).
A. Bes and G. Géraud, Circulation cérébrale; Physiopathologie, pp. 355–399, Sandoz, Paris 1974.
R. Katzman, R. Clasen, I. Klatzo, J. S. Meyer, H. M. Pappius and A. G. Waltz,Brain edema in stroke. Stroke8 (4), 512–540 (1977).
M. R. Goldberg and D. Robertson, Yohimbine: A Pharmacological Probe for Study of the α2-Adrenoreceptor. Pharmacol. Rev.35, 143–180 (1983).
C. A. Taube, A. Hauser, A. Duneman and W. Forster,Changes in prostaglandin synthesis in aorta, brain and kidney medulla of normal rats treated with antihypertensive drugs. Acta Biol. Med. Germ.37, 889–890 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robert, B., Petit, J.Y., Grimaud, N. et al. Effect of clonidine on experimental brain edema in the rat. Agents and Actions 37, 268–272 (1992). https://doi.org/10.1007/BF02028119
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02028119